Recent Quotes View Full List My Watchlist Create Watchlist Indicators DJI Nasdaq Composite SPX Gold Crude Oil EL&P Market Index Markets Stocks ETFs Tools Overview News Currencies International Treasuries Cocrystal Pharma Inc (NQ: COCP ) 2.210 -0.010 (-0.45%) Streaming Delayed Price Updated: 9:49 AM EDT, Jul 26, 2024 Add to My Watchlist Quote Overview Detailed Quote Charting Historical Prices News All News News Headlines Press Releases Research Quarterly Reports Insider Filings Other Filings Price and Volume Detailed Quote Volume 668 Open 2.210 Bid (Size) 2.200 (87) Ask (Size) 2.230 (4) Prev. Close 2.220 Today's Range 2.210 - 2.215 52wk Range 1.325 - 3.285 Shares Outstanding 10,173,790 Dividend Yield N/A Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year Top News More News COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q1 2024 May 13, 2024 COCP stock results show that Cocrystal Pharma beat analyst estimates for earnings per share the first quarter of 2024. Via InvestorPlace 12 Health Care Stocks Moving In Wednesday's Pre-Market Session April 10, 2024 Via Benzinga Performance YTD +25.73% +25.73% 1 Month -9.80% -9.80% 3 Month +46.36% +46.36% 6 Month +38.99% +38.99% 1 Year -16.92% -16.92% More News Read More COCP Stock Earnings: Cocrystal Pharma Beats EPS for Q4 2023 March 28, 2024 Via InvestorPlace Recap: Cocrystal Pharma Q4 Earnings March 28, 2024 Via Benzinga Cocrystal Pharma Discusses Antiviral Therapeutics' Clinical Development and 2024 Value Catalysts in New CEO Video Interview on Planet MicroCap March 05, 2024 Via ACCESSWIRE 12 Health Care Stocks Moving In Thursday's After-Market Session November 16, 2023 Via Benzinga Recap: Cocrystal Pharma Q3 Earnings November 13, 2023 Via Benzinga Analyst Ratings for Cocrystal Pharma August 15, 2023 Via Benzinga 12 Health Care Stocks Moving In Wednesday's After-Market Session November 15, 2023 Via Benzinga Why Cocrystal Pharma Shares Are Trading Higher Today April 10, 2023 Via Benzinga Why Tupperware Brands Shares Are Trading Lower By Over 40%? Here Are Other Stocks Moving In Monday's Mid-Day Session April 10, 2023 Via Benzinga $2M Bet On Cocrystal Pharma? Check Out These 3 Penny Stocks Insiders Are Aggressively Buying April 10, 2023 Via Benzinga Why Pioneer Natural Resources Shares Are Trading Higher By Around 7%; Here Are 20 Stocks Moving Premarket April 10, 2023 Via Benzinga 12 Health Care Stocks Moving In Friday's After-Market Session April 07, 2023 Via Benzinga Why eHealth Shares Are Trading Higher By Over 18%; Here Are 20 Stocks Moving Premarket January 25, 2023 Via Benzinga Cocrystal Pharma Discusses Clinical Progress and Significance of Its Novel Antiviral Therapeutics Pipeline with The Stock Day Podcast January 23, 2023 Via Newsfile Exposures COVID-19 Cocrystal Pharma Highlights Progress with CC-42344 as a Potential Oral Treatment for Pandemic and Seasonal Influenza A at the World Antiviral Congress 2022 December 01, 2022 From Cocrystal Pharma, Inc. Via GlobeNewswire Cocrystal Pharma Posts Favorable Safety Data From Oral Antiviral Against Influenza A November 17, 2022 Via Benzinga Cocrystal Pharma Announces Favorable Safety Data from the Phase 1 Study with Oral Antiviral CC-42344 for the Treatment of Pandemic and Seasonal Influenza A November 17, 2022 From Cocrystal Pharma, Inc. Via GlobeNewswire Stocks That Hit 52-Week Lows On Friday December 23, 2022 Via Benzinga Cocrystal Pharma Reports Third Quarter 2022 Financial Results and Provides Updates on its Antiviral Development Programs November 14, 2022 From Cocrystal Pharma, Inc. Via GlobeNewswire Why Tupperware Brands Shares Dipped Around 42%; Here Are 89 Biggest Movers From Yesterday November 03, 2022 Via Benzinga Why Benefitfocus Shares Are Trading Higher By Around 48%? Here Are 64 Stocks Moving In Wednesday's Mid-Day Session November 02, 2022 Via Benzinga Cocrystal Pharma to Participate in Two Investor Conferences in November November 02, 2022 From Cocrystal Pharma, Inc. Via GlobeNewswire Cocrystal Pharma Granted European Patent Covering Oral Antiviral Candidate CC-42344 in Combination with Another Antiviral Agent for the Treatment of Influenza November 01, 2022 From Cocrystal Pharma, Inc. Via GlobeNewswire Data & News supplied by www.cloudquote.io Stock quotes supplied by Barchart Quotes delayed at least 20 minutes. By accessing this page, you agree to the following Privacy Policy and Terms and Conditions.
